HEADER IMMUNE SYSTEM 21-JAN-14 4OJF TITLE HUMANISED 3D6 FAB COMPLEXED TO AMYLOID BETA 1-8 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HUMANISED 3D6 FAB HEAVY CHAIN; COMPND 3 CHAIN: H; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: HUMANISED 3D6 FAB LIGHT CHAIN; COMPND 7 CHAIN: L; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: AMYLOID BETA A4 PROTEIN; COMPND 11 CHAIN: A; COMPND 12 FRAGMENT: UNP RESIDUES 672-679; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 11 ORGANISM_COMMON: MOUSE; SOURCE 12 ORGANISM_TAXID: 10090; SOURCE 13 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 14 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 16 EXPRESSION_SYSTEM_CELL_LINE: HEK293; SOURCE 17 MOL_ID: 3; SOURCE 18 SYNTHETIC: YES; SOURCE 19 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 20 ORGANISM_COMMON: HUMAN; SOURCE 21 ORGANISM_TAXID: 9606; SOURCE 22 OTHER_DETAILS: SYNTHETIC PEPTIDE KEYWDS AMYLOID, BAPINEUZUMAB, 3D6, ALZHEIMER'S DISEASE, IMMUNOGLOBULIN, KEYWDS 2 IMMUNOTHERAPY, AMYLOID BETA, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR L.A.MILES,G.A.N.CRESPI,M.W.PARKER REVDAT 3 08-NOV-23 4OJF 1 REMARK REVDAT 2 22-NOV-17 4OJF 1 REMARK REVDAT 1 28-JAN-15 4OJF 0 JRNL AUTH G.A.N.CRESPI,D.B.ASCHER,M.W.PARKER,L.A.MILES JRNL TITL CRYSTALLIZATION AND PRELIMINARY X-RAY DIFFRACTION ANALYSIS JRNL TITL 2 OF THE FAB PORTION OF THE ALZHEIMER'S DISEASE IMMUNOTHERAPY JRNL TITL 3 CANDIDATE BAPINEUZUMAB COMPLEXED WITH AMYLOID-BETA JRNL REF ACTA CRYSTALLOGR.,SECT.F V. 70 374 2014 JRNL REFN ESSN 2053-230X JRNL PMID 24598931 JRNL DOI 10.1107/S2053230X14001642 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH L.A.MILES,G.A.N.CRESPI,L.DOUGHTY,M.W.PARKER REMARK 1 TITL BAPINEUZUMAB CAPTURES THE N-TERMINUS OF THE ALZHEIMER'S REMARK 1 TITL 2 DISEASE AMYLOID-BETA PEPTIDE IN A HELICAL CONFORMATION. REMARK 1 REF SCI REP V. 3 1302 2013 REMARK 1 REFN ESSN 2045-2322 REMARK 1 PMID 23416764 REMARK 1 DOI 10.1038/SREP01302 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8_1069 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.70 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 30735 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1546 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.7137 - 4.4423 1.00 2840 146 0.1849 0.2031 REMARK 3 2 4.4423 - 3.5265 1.00 2689 159 0.1598 0.1887 REMARK 3 3 3.5265 - 3.0809 1.00 2690 141 0.1770 0.2326 REMARK 3 4 3.0809 - 2.7993 1.00 2643 137 0.1826 0.2287 REMARK 3 5 2.7993 - 2.5987 1.00 2629 156 0.1772 0.2218 REMARK 3 6 2.5987 - 2.4455 1.00 2629 147 0.1746 0.2316 REMARK 3 7 2.4455 - 2.3230 1.00 2610 150 0.1616 0.2194 REMARK 3 8 2.3230 - 2.2219 1.00 2627 127 0.1609 0.2138 REMARK 3 9 2.2219 - 2.1364 1.00 2626 134 0.1497 0.2236 REMARK 3 10 2.1364 - 2.0626 1.00 2640 133 0.1669 0.1999 REMARK 3 11 2.0626 - 1.9982 0.98 2566 116 0.1722 0.2551 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.960 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3460 REMARK 3 ANGLE : 1.212 4693 REMARK 3 CHIRALITY : 0.069 522 REMARK 3 PLANARITY : 0.006 602 REMARK 3 DIHEDRAL : 13.979 1244 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4OJF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-JAN-14. REMARK 100 THE DEPOSITION ID IS D_1000084568. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-OCT-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30773 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.998 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 14.40 REMARK 200 R MERGE (I) : 0.10400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 14.60 REMARK 200 R MERGE FOR SHELL (I) : 0.36900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4HIX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.27 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES, 25%(W/V) PEG 6000, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,-Y,-Z+1/2 REMARK 290 4555 -X+1/2,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 30.08100 REMARK 290 SMTRY2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.12400 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 30.08100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 44.12400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH H 427 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER H 215 REMARK 465 CYS H 216 REMARK 465 HIS H 217 REMARK 465 HIS H 218 REMARK 465 HIS H 219 REMARK 465 HIS H 220 REMARK 465 HIS H 221 REMARK 465 HIS H 222 REMARK 465 ASP A 7 REMARK 465 SER A 8 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN H 192 H THR H 193 1.50 REMARK 500 O HIS L 189 HH11 ARG L 211 1.51 REMARK 500 OE2 GLU L 187 NH2 ARG L 211 2.12 REMARK 500 O HOH L 345 O HOH L 435 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS H 43 -168.64 -116.03 REMARK 500 ALA H 88 164.36 177.22 REMARK 500 ASP H 101 -77.09 -118.74 REMARK 500 PRO H 126 137.13 -37.69 REMARK 500 SER H 130 -2.38 -153.62 REMARK 500 ASP H 144 64.16 71.22 REMARK 500 ASN H 155 47.18 39.05 REMARK 500 SER H 188 13.43 -68.38 REMARK 500 VAL L 51 -48.62 76.10 REMARK 500 LEU L 125 38.52 -90.71 REMARK 500 LYS L 126 36.96 -155.10 REMARK 500 SER L 127 23.14 -147.20 REMARK 500 SER L 156 120.27 -176.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER H 130 THR H 131 -149.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4HIX RELATED DB: PDB REMARK 900 SAME STRUCTURE BUT DIFFERENT LENGTH AMYLOID-BETA DBREF 4OJF H 2 222 PDB 4OJF 4OJF 2 222 DBREF 4OJF L 1 214 PDB 4OJF 4OJF 1 214 DBREF 4OJF A 1 8 UNP P05067 A4_HUMAN 672 679 SEQRES 1 H 227 VAL GLN LEU LEU GLU SER GLY GLY GLY LEU VAL GLN PRO SEQRES 2 H 227 GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY PHE SEQRES 3 H 227 THR PHE SER ASN TYR GLY MET SER TRP VAL ARG GLN ALA SEQRES 4 H 227 PRO GLY LYS GLY LEU GLU TRP VAL ALA SER ILE ARG SER SEQRES 5 H 227 GLY GLY GLY ARG THR TYR TYR SER ASP ASN VAL LYS GLY SEQRES 6 H 227 ARG PHE THR ILE SER ARG ASP ASN ALA LYS ASN SER LEU SEQRES 7 H 227 TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR ALA SEQRES 8 H 227 LEU TYR TYR CYS VAL ARG TYR ASP HIS TYR SER GLY SER SEQRES 9 H 227 SER ASP TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 10 H 227 SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 11 H 227 PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU SEQRES 12 H 227 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLN PRO VAL THR SEQRES 13 H 227 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 14 H 227 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 15 H 227 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 16 H 227 THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER SEQRES 17 H 227 ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SER CYS SEQRES 18 H 227 HIS HIS HIS HIS HIS HIS SEQRES 1 L 219 TYR VAL VAL MET THR GLN SER PRO LEU SER LEU PRO VAL SEQRES 2 L 219 THR PRO GLY GLU PRO ALA SER ILE SER CYS LYS SER SER SEQRES 3 L 219 GLN SER LEU LEU ASP SER ASP GLY LYS THR TYR LEU ASN SEQRES 4 L 219 TRP LEU LEU GLN LYS PRO GLY GLN SER PRO GLN ARG LEU SEQRES 5 L 219 ILE TYR LEU VAL SER LYS LEU ASP SER GLY VAL PRO ASP SEQRES 6 L 219 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 219 LYS ILE SER ARG VAL GLU ALA GLU ASP VAL GLY VAL TYR SEQRES 8 L 219 TYR CYS TRP GLN GLY THR HIS PHE PRO ARG THR PHE GLY SEQRES 9 L 219 GLN GLY THR LYS VAL GLU ILE LYS ARG THR VAL ALA ALA SEQRES 10 L 219 PRO SER VAL PHE ILE PHE PRO PRO SER ASP GLU GLN LEU SEQRES 11 L 219 LYS SER GLY THR ALA SER VAL VAL CYS LEU LEU ASN ASN SEQRES 12 L 219 PHE TYR PRO ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP SEQRES 13 L 219 ASN ALA LEU GLN SER GLY ASN SER GLN GLU SER VAL THR SEQRES 14 L 219 GLU GLN ASP SER LYS ASP SER THR TYR SER LEU SER SER SEQRES 15 L 219 THR LEU THR LEU SER LYS ALA ASP TYR GLU LYS HIS LYS SEQRES 16 L 219 VAL TYR ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER SEQRES 17 L 219 PRO VAL THR LYS SER PHE ASN ARG GLY GLU CYS SEQRES 1 A 8 ASP ALA GLU PHE ARG HIS ASP SER FORMUL 4 HOH *302(H2 O) HELIX 1 1 THR H 28 TYR H 32 5 5 HELIX 2 2 ASN H 73 LYS H 75 5 3 HELIX 3 3 ARG H 83 THR H 87 5 5 HELIX 4 4 SER H 156 ALA H 158 5 3 HELIX 5 5 PRO H 185 LEU H 189 5 5 HELIX 6 6 LYS H 201 ASN H 204 5 4 HELIX 7 7 GLU L 79 VAL L 83 5 5 HELIX 8 8 GLU L 123 SER L 127 5 5 HELIX 9 9 ASP A 1 ARG A 5 5 5 SHEET 1 A 4 GLN H 3 SER H 7 0 SHEET 2 A 4 LEU H 18 SER H 25 -1 O SER H 25 N GLN H 3 SHEET 3 A 4 SER H 77 MET H 82 -1 O MET H 82 N LEU H 18 SHEET 4 A 4 PHE H 67 ASP H 72 -1 N SER H 70 O TYR H 79 SHEET 1 B 6 LEU H 11 VAL H 12 0 SHEET 2 B 6 THR H 107 VAL H 111 1 O THR H 110 N VAL H 12 SHEET 3 B 6 ALA H 88 ASP H 96 -1 N ALA H 88 O VAL H 109 SHEET 4 B 6 MET H 34 GLN H 39 -1 N VAL H 37 O TYR H 91 SHEET 5 B 6 LEU H 45 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 B 6 THR H 57 TYR H 59 -1 O TYR H 58 N SER H 50 SHEET 1 C 4 LEU H 11 VAL H 12 0 SHEET 2 C 4 THR H 107 VAL H 111 1 O THR H 110 N VAL H 12 SHEET 3 C 4 ALA H 88 ASP H 96 -1 N ALA H 88 O VAL H 109 SHEET 4 C 4 SER H 100A TRP H 103 -1 O TYR H 102 N ARG H 94 SHEET 1 D 4 SER H 120 LEU H 124 0 SHEET 2 D 4 ALA H 136 TYR H 145 -1 O GLY H 139 N LEU H 124 SHEET 3 D 4 TYR H 176 VAL H 184 -1 O VAL H 184 N ALA H 136 SHEET 4 D 4 VAL H 163 THR H 165 -1 N HIS H 164 O VAL H 181 SHEET 1 E 4 SER H 120 LEU H 124 0 SHEET 2 E 4 ALA H 136 TYR H 145 -1 O GLY H 139 N LEU H 124 SHEET 3 E 4 TYR H 176 VAL H 184 -1 O VAL H 184 N ALA H 136 SHEET 4 E 4 VAL H 169 LEU H 170 -1 N VAL H 169 O SER H 177 SHEET 1 F 3 THR H 151 TRP H 154 0 SHEET 2 F 3 ILE H 195 HIS H 200 -1 O ASN H 197 N SER H 153 SHEET 3 F 3 THR H 205 LYS H 210 -1 O LYS H 209 N CYS H 196 SHEET 1 G 4 MET L 4 SER L 7 0 SHEET 2 G 4 ALA L 19 SER L 25 -1 O LYS L 24 N THR L 5 SHEET 3 G 4 ASP L 70 ILE L 75 -1 O LEU L 73 N ILE L 21 SHEET 4 G 4 PHE L 62 SER L 67 -1 N SER L 63 O LYS L 74 SHEET 1 H 6 SER L 10 VAL L 13 0 SHEET 2 H 6 THR L 102 ILE L 106 1 O LYS L 103 N LEU L 11 SHEET 3 H 6 GLY L 84 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 H 6 LEU L 33 GLN L 38 -1 N GLN L 38 O VAL L 85 SHEET 5 H 6 GLN L 45 TYR L 49 -1 O LEU L 47 N TRP L 35 SHEET 6 H 6 LYS L 53 LEU L 54 -1 O LYS L 53 N TYR L 49 SHEET 1 I 4 SER L 10 VAL L 13 0 SHEET 2 I 4 THR L 102 ILE L 106 1 O LYS L 103 N LEU L 11 SHEET 3 I 4 GLY L 84 GLN L 90 -1 N TYR L 86 O THR L 102 SHEET 4 I 4 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SHEET 1 J 4 SER L 114 PHE L 118 0 SHEET 2 J 4 THR L 129 PHE L 139 -1 O LEU L 135 N PHE L 116 SHEET 3 J 4 TYR L 173 SER L 182 -1 O LEU L 181 N ALA L 130 SHEET 4 J 4 SER L 159 VAL L 163 -1 N GLN L 160 O THR L 178 SHEET 1 K 3 LYS L 145 VAL L 150 0 SHEET 2 K 3 TYR L 192 THR L 197 -1 O GLU L 195 N GLN L 147 SHEET 3 K 3 VAL L 205 PHE L 209 -1 O VAL L 205 N VAL L 196 SSBOND 1 CYS H 22 CYS H 92 1555 1555 2.10 SSBOND 2 CYS H 140 CYS H 196 1555 1555 2.05 SSBOND 3 CYS L 23 CYS L 88 1555 1555 2.10 SSBOND 4 CYS L 134 CYS L 194 1555 1555 2.05 CISPEP 1 SER H 128 LYS H 129 0 10.07 CISPEP 2 LYS H 129 SER H 130 0 -4.90 CISPEP 3 PHE H 146 PRO H 147 0 -3.81 CISPEP 4 GLN H 148 PRO H 149 0 6.31 CISPEP 5 SER L 7 PRO L 8 0 -6.52 CISPEP 6 PHE L 94 PRO L 95 0 6.06 CISPEP 7 TYR L 140 PRO L 141 0 3.97 CRYST1 60.162 83.430 88.248 90.00 90.00 90.00 P 21 2 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016622 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011986 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011332 0.00000